Účinnost a bezpečnost monoterapie satralizumabem u NMOSD

(rubrika: , autor: Zdroj: Traboulsee A et al. Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double‑blind, multicentre, placebo‑controlled phase 3 trial. Lancet Neurol 2020;19:402–412, zdroj: MT)